Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEFOPAM vs NELARABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEFOPAM vs NELARABINE: Safety Overview

Metric NEFOPAM NELARABINE
Total FAERS Reports 2,857 735
Deaths Reported 360 156
Death Rate 12.6% 21.2%
Hospitalizations 1,685 265
Average Patient Age 55.0 yrs 29.3 yrs
% Female Patients 54.4% 30.1%
FDA Approval Date N/A Apr 4, 2023
Manufacturer N/A Amneal Pharmaceuticals LLC
Route N/A INTRAVENOUS
Marketing Status N/A Prescription